Erica Jordan - Chief Commercial Officer at Revance Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Officer
Stock Symbol
RVNC on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Erica Jordan - trading volume in the past year for Revance Therapeutics, Inc.

Holdings reported by Erica Jordan for Revance Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 114,864 $437 K $3.80 Apr 16, 2024 Direct

Transactions reported by Erica Jordan for Revance Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership